tert-Butyl (2S)-2-(2-methoxy-2-oxoethyl)piperazine-1-carboxylate, 98+%, 1g

3,5,6-Tribromopyridin-2-amine, 95.0%, 1g

rac 1-Methyl-piperidine-2-carbonitrile, 96.0%, 1g

3,5-Diamino-2,4,6-trimethylbenzenesulfonic acid, 95.0%, 25g

2,5-dioxopyrrolidin-1-yl 2-(cyclooct-2-ynyloxy)acetate, 100mg

(4-Chloro-2-propoxyphenyl)boronic acid, 95.0%, 250mg

1,1'-Dibutyrylferrocene>98.0%(GC)5g

(S)-4-(tert-butyl)-2-(2-(diphenylphosphanyl)-5-(trifluoromethyl)phenyl)-4,5-dihydrooxazole, 98%, 100mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-5-((tert-butoxycarbonyl)amino)pentanoic acid, 97%, 10g

5-TRIFLUOROMETHYL-THIOPHENE-3-CARBOXYLIC ACID METHYL ESTER, 90.0%, 1g

[3-(TRIFLUOROMETHYL)PHENYL](2,4,6-TRIMETHYLPHENYL)IODONIUM TRIFLUOROMETHANESULFONATE, 98%, 250mg

Isobutyl Isobutyrate>98.0%(GC)25mL

Gal alpha(1-3) core 6-Fucosylated N-Glycan 2AB (500pmol/vial)>98.0%(HPLC)1vial